The Pennant Group/$PNTG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About The Pennant Group
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
Ticker
$PNTG
Sector
Primary listing
Employees
7,000
Headquarters
Website
PNTG Metrics
BasicAdvanced
$884M
33.14
$0.77
1.48
-
Price and volume
Market cap
$884M
Beta
1.48
52-week high
$35.75
52-week low
$21.18
Average daily volume
426K
Financial strength
Current ratio
1.214
Quick ratio
1.049
Long term debt to equity
89.484
Total debt to equity
95.785
Interest coverage (TTM)
7.26%
Profitability
EBITDA (TTM)
50.669
Gross margin (TTM)
20.65%
Net profit margin (TTM)
3.36%
Operating margin (TTM)
5.41%
Effective tax rate (TTM)
23.02%
Revenue per employee (TTM)
$110,000
Management effectiveness
Return on assets (TTM)
3.99%
Return on equity (TTM)
11.72%
Valuation
Price to earnings (TTM)
33.139
Price to revenue (TTM)
1.069
Price to book
2.84
Price to tangible book (TTM)
22.51
Price to free cash flow (TTM)
106.405
Free cash flow yield (TTM)
0.94%
Free cash flow per share (TTM)
0.24
Growth
Revenue change (TTM)
30.58%
Earnings per share change (TTM)
20.56%
3-year revenue growth (CAGR)
20.74%
3-year earnings per share growth (CAGR)
102.53%
What the Analysts think about PNTG
Analyst ratings (Buy, Hold, Sell) for The Pennant Group stock.
Bulls say / Bears say
Total Q2 2025 revenue of $219.5 million represented a 30.1% year-over-year increase, surpassing analyst expectations and demonstrating robust top-line momentum (Reuters)
Home Health and Hospice segment revenue rose 32.5% in Q2 2025, driven by a 26.1% increase in home health admissions, underscoring strong organic growth in Pennant’s core services (Reuters)
Management raised full-year 2025 guidance to revenue of $852.8 million–$887.6 million and adjusted EPS of $1.09–$1.15, implying 19.1% EPS growth and reflecting confidence in sustained operating momentum (Reuters)
The CMS’s proposed 6.4% net cut to home health Medicare payments for 2026 would reduce sector payments by an estimated $1.1 billion and could materially compress margins in Pennant’s core home health and hospice segment (Reuters)
Pennant’s updated 2025 guidance factors in expenses for the pending UnitedHealth/Amedisys transaction without anticipating earnings from the deal, underscoring uncertainty around its timing and potential dilution to adjusted EPS (Reuters)
Senior Living Services revenue growth of 23.1% in Q2 was driven largely by higher revenue per occupied room rather than increased occupancy, indicating reliance on pricing power amid flat utilization and limited volume upside (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.
PNTG Financial Performance
Revenues and expenses
PNTG Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for The Pennant Group stock?
The Pennant Group (PNTG) has a market cap of $884M as of September 15, 2025.
What is the P/E ratio for The Pennant Group stock?
The price to earnings (P/E) ratio for The Pennant Group (PNTG) stock is 33.14 as of September 15, 2025.
Does The Pennant Group stock pay dividends?
No, The Pennant Group (PNTG) stock does not pay dividends to its shareholders as of September 15, 2025.
When is the next The Pennant Group dividend payment date?
The Pennant Group (PNTG) stock does not pay dividends to its shareholders.
What is the beta indicator for The Pennant Group?
The Pennant Group (PNTG) has a beta rating of 1.48. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.